1,4-dihydropyridines for application in combatting resistance to drugs
AssigneeByk Gulden Lomberg Chemische Fabrik GmbH
InventorWolf-Rudiger Ulrich
Life of this patent
Estimating the term…
Abstract
Optically pure diaryl compounds of formula (I), in which the substituents and symbols have the meanings indicated in the description are proposed as active ingredients in medicinal preparations for treating tumorous diseases. ##STR1##
Claims2
A medicament composition which comprises, in addition to an effective amount of the active ingredient selected from the group consisting of vincristine, daunomycin, doxorubicin and etoposide, a synergistically-effective amount of optically-pure (R)-(+)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxyl ic acid 3-methyl 5- 3-(4,4-diphenyl-1-piperidinyl)-propyl!ester, or a pharmacologically-tolerated salt thereof, to improve the action of or to overcome resistance to the active ingredient.
A method of synergistically improving action of or overcoming resistance toward a medicament composition used in therapy and comprising, as active component, an effective amount of a member selected from the group consisting of vincristine, daunomycin, doxorubicin and etoposide, which comprises administering to a patient in need of such therapy a synergistically-effective amount of optically-pure (R)-(+)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxyl ic acid 3-methyl 5- 3-(4,4-diphenyl-1-piperidinyl)-propyl!ester or a pharmacologically-tolerated salt thereof, in addition to the medicament composition.
Dependencies are inferred from the claim text.